50 Participants Needed

Group Advance Care Planning for Cancer

MI
Overseen ByManali I Patel, MD MPH MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Group Advance Care Planning Education for cancer?

Research shows that advance care planning (ACP) helps ensure that patients' end-of-life wishes are followed, increases satisfaction for both patients and families, and reduces stress, anxiety, and depression for families. This suggests that group ACP education could be beneficial for cancer patients by improving communication and decision-making about future health care.12345

Is Group Advance Care Planning generally safe for humans?

There is no specific safety data available for Group Advance Care Planning, but non-drug trials in palliative care, like this one, often focus on managing serious adverse events, which can include psychological distress. These events are usually related to the progression of the disease rather than the trial itself.678910

How is the Group Advance Care Planning Education treatment different from other treatments for cancer?

Group Advance Care Planning Education is unique because it focuses on helping patients with cancer plan their future healthcare decisions, improving communication and aligning care with their wishes, rather than directly treating the cancer itself. This approach is particularly beneficial for older adults who often face barriers to completing advance care planning.1112131415

What is the purpose of this trial?

The proposed research aims to engage participants with an advanced stage cancer diagnosis in group educational sessions to facilitate learning of topics related to advanced care planning. The investigators also hope to learn if conducting educational sessions in a group setting helps to create a more supportive environment amongst patients, caregivers, etc.

Eligibility Criteria

This trial is for veterans with an advanced stage cancer diagnosis. It's designed to help them learn about advanced care planning through group educational sessions, which may also provide a supportive environment.

Inclusion Criteria

2. Patients must have the ability to understand and willingness to provide verbal consent

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants engage in group advanced care planning sessions or receive usual care

8 weeks
2 sessions (in-person or virtual)

Follow-up

Participants are monitored for documentation of goals of care and other secondary outcomes

8 weeks

Treatment Details

Interventions

  • Group Advance Care Planning Education
Trial Overview The intervention being studied is Group Advance Care Planning Education. The goal is to see if learning in a group setting can improve understanding and support among patients and caregivers dealing with advanced cancer.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Group Advance Care PlanningExperimental Treatment1 Intervention
The participant will engage in 2 hours of educational sessions regarding advance care planning and goals of care. They will be interviewed which is expected to last 20-30 min and surveys will last 15-20 min. The total involvement will be no more than 3 hours and 40 min over 8 weeks.
Group II: Usual CareActive Control1 Intervention
The patient will continue to receive as normal and usual. The participants will be interviewed which is expected to last 20-30 min. Surveys will last 15-20 min. The total possible time is 1 hour and 40 min. for both baseline and post over 8 week period.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

US Department of Veterans Affairs

Collaborator

Trials
881
Recruited
502,000+

Findings from Research

Advance care planning (ACP) is crucial for enhancing the quality of end-of-life care for cancer patients, as it allows them to make informed decisions about their future health care in collaboration with healthcare providers and family.
Implementing ACP leads to better adherence to patients' end-of-life wishes, increased satisfaction for both patients and families, and a reduction in family-related stress, anxiety, and depression.
[Advance Care Planning in Cancer Care].Kizawa, Y., Yamaguchi, T., Yotani, N.[2016]
In a study of 456 patients with terminal cancer, only 6% had documented care goals in case of acute deterioration, highlighting a significant gap in advance care planning.
A quality improvement initiative was launched to enhance documentation and referral rates to palliative care, aiming to ensure better patient support and care planning in the future.
Toward improved goals-of-care documentation in advanced cancer: report on the development of a quality improvement initiative.Harle, I., Karim, S., Raskin, W., et al.[2022]
A significant number of health professionals (62.5% in primary care and 72.5% in hospitals) reported experiencing emotional distress as 'second victims' after adverse events, indicating a widespread impact on their mental well-being.
Feelings of guilt, anxiety, and insecurity were the most common emotional responses among these professionals, highlighting the need for better training and support systems to help them cope with the psychological effects of adverse events.
The aftermath of adverse events in Spanish primary care and hospital health professionals.Mira, JJ., Carrillo, I., Lorenzo, S., et al.[2022]

References

[Advance Care Planning in Cancer Care]. [2016]
Advance care planning in patients with incurable cancer: study protocol for a randomised controlled trial. [2019]
Can a patient-directed video improve inpatient advance care planning? A prospective pre-post cohort study. [2020]
Medical oncology outpatients' preferences and experiences with advanced care planning: a cross-sectional study. [2020]
Toward improved goals-of-care documentation in advanced cancer: report on the development of a quality improvement initiative. [2022]
An Unsupervised Machine Learning Approach to Evaluating the Association of Symptom Clusters With Adverse Outcomes Among Older Adults With Advanced Cancer: A Secondary Analysis of a Randomized Clinical Trial. [2023]
One fourth of unplanned transfers to a higher level of care are associated with a highly preventable adverse event: a patient record review in six Belgian hospitals. [2018]
The aftermath of adverse events in Spanish primary care and hospital health professionals. [2022]
Registry of adverse events related to health care that results in deaths in Brazil, 2014-2016. [2019]
What should we report? Lessons learnt from the development and implementation of serious adverse event reporting procedures in non-pharmacological trials in palliative care. [2021]
Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly (ACP-PEACE): the study protocol for a pragmatic stepped-wedge trial of older patients with cancer. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
The PREPARE for Your Care program increases advance care planning engagement among diverse older adults with cancer. [2022]
Is an advance care planning model feasible in community palliative care? A multi-site action research approach. [2019]
The economic evidence for advance care planning: Systematic review of evidence. [2018]
Effects of an advance care planning educational programme intervention on the end-of-life care attitudes of multidisciplinary practitioners at an acute hospital: A pre- and post-study. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security